JUN 17, 2020 10:30 AM PDT

Applications of Flow Cytometry and Imaging Flow Cytometry to COVID-19 Research

Sponsored by: LUMINEX
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

COVID 19 has resulted in diverse research needs ranging from mechanism and impact of the disease, to solutions to identify, combat or treat the disease.  Cellular technologies such as flow and imaging cytometry can provide powerful information in this discovery process. In this webinar we will discuss cellular technologies and solutions available from Luminex Corporation to aid COVID 19 research.  Our Guava® Muse® and Guava® easyCyte™ platforms leverage the power of microcapillary cytometry and small sample sizes to provide quick, rapid methods for cellular counts and viability as well as characterization of immune cells providing information such as  absolute CD4 T , CD8 T cell, B cells and total lymphocytes with ease.  The webinar will also discuss cell health assays and capabilities on the platforms that allow for quick assessment of apoptosis and cytotoxicity from compound treatments especially in drug repurposing studies.

Our imaging cytometry platform, the ImageStream®X Mk II combines the quantitative power of flow cytometry with the spatial information provided by microscopy into one system. The ImageStream classifies cell images not only based on fluorescence intensity but the relative distribution of that intensity as well as morphology. The platform provides the capability to study signaling cascades and translocation of transcription factors, which may be important in immune cell activation and host defense against pathogens. It also provides the capability to study white blood cell sub types of interest using morphologic and fluorescence parameters.  The ImageStream® can also measure individual fluorescently labeled viruses; the new High Gain mode for the ImageStream®X Mk II increases the signal obtained from these small viruses while minimally increasing the noise. In this presentation 3 applications will be discussed for the ImageStream®, individual murine leukemia virus-sfGFP reference particles demonstrating High Gain mode, shape change, and nuclear translocation.

Learning Objectives:

1. Important questions  of COVID 19 research that can be tackled using flow cytometry

2. Instrument and assay tools available on Muse and Guava platforms for COVID 19 research

3. Imaging flow cytometry enables applications that can’t be performed by flow cytometry or microscopy alone.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
OCT 12, 2021 9:00 AM PDT
C.E. CREDITS
OCT 12, 2021 9:00 AM PDT
Date: October 12, 2021 Time: 9:00am (PDT), 12:00pm (EDT) SCIEX’s next-generation Biologics Explorer software is an innovative platform for the comprehensive and deep characterization o...
OCT 27, 2021 6:00 AM PDT
C.E. CREDITS
OCT 27, 2021 6:00 AM PDT
Date: October 27, 2021 Time: 6:00 AM PDT, 9:00 AM EDT Etanercept is a recombinant Fc fusion protein therapeutic that has a complex distribution of post-translation modifications (PTM), such...
Loading Comments...
Show Resources